|
N- (3- {[α- D- GalN- (1→4)- α- D- GalN- yl]oxy}propyl)- 21- (biotinylamino)- 4,7,10,13,16,19- hexaoxadodecan- 1- amide |
|
CHEBI:146255 |
|
N- (3- {[alpha- D- GalN- (1- >4)- alpha- D- GalN- yl]oxy}propyl)- 21- (biotinylamino)- 4,7,10,13,16,19- hexaoxadodecan- 1- amide |
|
A disaccharide derivative in which α-D-galactosaminyl-(1→4)-α-D-galactosamine is linked glycosidically to biotin via a (21-oxo-3,6,9,12,15,18-hexaoxa-22-azapentacosan-1-yl)amino spacer. One of a set of synthesised biotinylated oligo-α-(1→4)-D-galactosamines comprising from two to six monosaccharide units, along with their N-acetylated derivatives (PMID:31913631), aimed at analysing the specificity of the antibody responses to a complex exopolysaccharide galactosaminogalactan found in Aspergillus fumigatus, the most important airborne human fungal pathogen in industrialized countries. |
|
![](images/goldenstar.gif) ![](images/goldenstar.gif)
This entity has been manually annotated by the ChEBI Team.
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C40H74N6O18S/c41- 31- 35(52) 34(51) 26(22- 47) 62- 39(31) 64- 37- 27(23- 48) 63- 38(32(42) 36(37) 53) 61- 9- 3- 7- 43- 30(50) 6- 10- 55- 12- 14- 57- 16- 18- 59- 20- 21- 60- 19- 17- 58- 15- 13- 56- 11- 8- 44- 29(49) 5- 2- 1- 4- 28- 33- 25(24- 65- 28) 45- 40(54) 46- 33/h25- 28,31- 39,47- 48,51- 53H,1- 24,41- 42H2,(H,43,50) (H,44,49) (H2,45,46,54) /t25- ,26+,27+,28- ,31+,32+,33- ,34- ,35+,36+,37- ,38- ,39+/m0/s1 |
SJABWFIFUAMIDU-ZKLAHFGVSA-N |
[C@H] 1([C@@H] ([C@H] ([C@H] ([C@H] (O1) CO) O) O) N) O[C@@H] 2[C@@H] ([C@H] ([C@H] (O[C@@H] 2CO) OCCCNC(CCOCCOCCOCCOCCOCCOCCNC(CCCC[C@H] 3[C@] 4(NC(N[C@] 4(CS3) [H] ) =O) [H] ) =O) =O) N) O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
View more via ChEBI Ontology
Outgoing
|
N- (3- {[α- D- GalN- (1→4)- α- D- GalN- yl]oxy}propyl)- 21- (biotinylamino)- 4,7,10,13,16,19- hexaoxadodecan- 1- amide
(CHEBI:146255)
is a
biotins
(CHEBI:51570)
N- (3- {[α- D- GalN- (1→4)- α- D- GalN- yl]oxy}propyl)- 21- (biotinylamino)- 4,7,10,13,16,19- hexaoxadodecan- 1- amide
(CHEBI:146255)
is a
disaccharide derivative
(CHEBI:63353)
|
|
N- (3- {[2- amino- 2- deoxy- α- D- galactopyranosyl- (1→4)- 2- amino- 2- deoxy- α- D- galactopyranosyl]oxy}propyl)- 23- oxo- 27- [(3aS,4S,6aR)- 2- oxohexahydro- 1H- thieno[3,4- d]imidazol- 4- yl]- 4,7,10,13,16,19- hexaoxa- 22- azaheptacosan- 1- amide
|
(3aS,4S,6aR)- N- [25- [[2- amino- 4- O- (2- amino- 2- deoxy- α- D- galactopyranosyl)- 2- deoxy- α- D- galactopyranosyl]oxy]- 21- oxo- 3,6,9,12,15,18- hexaoxa- 22- azapentacos- 1- yl]hexahydro- 2- oxo- 1H- thieno[3,4- d]imidazole- 4- pentanamide
|
ChEBI
|
3- (21- biotinamino- 4,7,10,13,16,19- hexaoxagenicaminoamino)- propyl 2- amino- 2- deoxy- α- D- galactopyranosyl- (1→4)- 2- amino- 2- deoxy- α- D- galactopyranoside
|
ChEBI
|
N- (3- {[2- amino- 4- O- (2- amino- 2- deoxy- α- D- galactopyranosyl)- 2- deoxy- α- D- galactopyranosyl]oxy}propyl)- 23- oxo- 27- [(3aS,4S,6aR)- 2- oxohexahydro- 1H- thieno[3,4- d]imidazol- 4- yl]- 4,7,10,13,16,19- hexaoxa- 22- azaheptacosan- 1- amide
|
IUPAC
|
N- (3- {[α- D- galactosaminyl- (1→4)- α- D- galactosaminyl]oxy}propyl)- 21- (biotinylamino)- 4,7,10,13,16,19- hexaoxaheptacosan- 1- amide
|
ChEBI
|
31913631
|
PubMed citation
|
Europe PMC
|
|